本文選題：化痰活血法 + 后循環(huán)缺血��； 參考：《長春中醫(yī)藥大學(xué)》2016年碩士論文

【摘要】：目的:觀察化痰活血定眩飲治療后循環(huán)缺血性眩暈(痰瘀阻竅證)的臨床療效和安全性。方法:根據(jù)入組標(biāo)準(zhǔn),選取后循環(huán)缺血性眩暈(痰瘀阻竅證)病例72例,隨機(jī)分為治療組和對照組。治療組予化痰活血定眩飲,每次100ml,早晚各1次口服;對照組予甲磺酸倍他司汀片6mg,日3次口服。療程為14天,治療前后分別進(jìn)行療效及安全性觀察,并進(jìn)行統(tǒng)計學(xué)分析。結(jié)果:分別比較治療組和對照組治療前、后眩暈嚴(yán)重程度評分,差異有統(tǒng)計學(xué)意義(P0.05);比較治療組和對照組治療后眩暈嚴(yán)重程度評分,差異有統(tǒng)計學(xué)意義(P0.05)。比較治療組治療前、后單項中醫(yī)證候積分,差異有統(tǒng)計學(xué)意義(P0.05);比較治療組和對照組治療后單項中醫(yī)證候積分,差異有統(tǒng)計學(xué)意義(P0.05);比較治療組和對照組中醫(yī)證候總有效率,差異有統(tǒng)計學(xué)意義(P0.05)。分別比較治療組和對照組治療前、后TCD指標(biāo)改善情況,差異有統(tǒng)計學(xué)意義(P0.05);比較治療組和對照組治療后TCD指標(biāo)改善情況,差異有統(tǒng)計學(xué)意義(P0.05)。兩組治療過程中均未出現(xiàn)不良反應(yīng)及毒副作用。臨床研究表明,治療組在改善后循環(huán)缺血性眩暈患者的眩暈嚴(yán)重程度、中醫(yī)證候和TCD相關(guān)指標(biāo)方面均優(yōu)于對照組。結(jié)論:以化痰活血法為治療原則,應(yīng)用化痰活血定眩飲治療后循環(huán)缺血性眩暈(痰瘀阻竅證)療效確切,且無不良反應(yīng)。
[Abstract]:Objective: to observe the clinical efficacy and safety of Huatan Huoxue Dingxuan decoction (Huatan Huoxue Dingxuan decoction) in treating circulatory ischemic vertigo.Methods: 72 cases of posterior circulation ischemic vertigo (phlegm stasis syndrome) were randomly divided into treatment group and control group.The treatment group was treated with Huatan Huoxue Dingxuan decoction (100ml / time) and the control group (6mg / day).The course of treatment was 14 days. The curative effect and safety were observed before and after treatment, and statistical analysis was carried out.Results: the scores of vertigo severity before and after treatment were compared between the treatment group and the control group, the difference was statistically significant (P 0.05), while that of the treatment group and the control group was significantly higher than that of the control group (P 0.05).Before and after treatment, the difference between the treatment group and the control group was statistically significant (P 0.05), the difference between the treatment group and the control group was statistically significant (P 0.05), and the total effective rate of the treatment group and the control group was higher than that of the control group.The difference was statistically significant (P 0.05).The improvement of TCD in treatment group and control group was compared before and after treatment, the difference was statistically significant (P 0.05), and the improvement of TCD index in treatment group and control group was statistically significant (P 0.05).There were no adverse reactions and side effects in both groups.The clinical study showed that the treatment group was superior to the control group in improving the severity of vertigo, TCM syndromes and TCD related indexes in patients with posterior circulatory ischemic vertigo.Conclusion: using Huatan Huoxue Dingxuan decoction as the treatment principle, the therapeutic effect of Huatan Huoxue Dingxuan decoction on circulation ischemic vertigo (phlegm stasis obstruction of orifices) is definite, and there is no adverse reaction.
【學(xué)位授予單位】：長春中醫(yī)藥大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2016
【分類號】：R255.3

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 胡小東;王鵬琴;;眼體針結(jié)合治療后循環(huán)缺血性眩暈40例[J];針灸臨床雜志;2016年01期

2 單豐;;半夏白術(shù)天麻湯治療后循環(huán)缺血性眩暈的臨床療效觀察[J];北方藥學(xué);2015年09期

3 潘雪;馬端鑫;李燕;林亞明;;水蛭藥理作用的研究進(jìn)展[J];中國民族民間醫(yī)藥;2015年14期

4 張玉龍;王夢月;楊靜玉;李曉波;;炙甘草化學(xué)成分及藥理作用研究進(jìn)展[J];上海中醫(yī)藥大學(xué)學(xué)報;2015年03期

5 凌爽;畢悅;翟慧穎;楊茂波;牛雯穎;紀(jì)博碩;肖洪彬;;痰瘀阻絡(luò)模型大鼠血液流變學(xué)及紅細(xì)胞膜生物學(xué)研究[J];中醫(yī)藥學(xué)報;2015年02期

6 董寶杰;鄒憶懷;孫靜;;加味澤瀉湯治療水飲上泛型后循環(huán)缺血性眩暈的療效觀察[J];血栓與止血學(xué);2015年02期

7 朱穎玲;唐曉華;潘平雷;;自擬健脾化痰定眩飲治療后循環(huán)缺血性眩暈臨床觀察[J];陜西中醫(yī);2015年02期

8 丁明俊;蔡圣朝;楚二星;;百會實按灸結(jié)合針刺治療后循環(huán)缺血性眩暈臨床療效觀察[J];中醫(yī)藥臨床雜志;2015年01期

9 趙紅衛(wèi);劉艷新;范波勝;;低分子肝素鈣聯(lián)合長春西汀治療后循環(huán)缺血性眩暈的療效[J];中國實用神經(jīng)疾病雜志;2014年17期

10 馮瑩瑩;;半夏瀉心湯加味治療后循環(huán)缺血性眩暈46例臨床觀察[J];湖南中醫(yī)雜志;2014年08期

，

本文編號：1749104